New psoriasis drug shows promise in chinese trial
NCT ID NCT06011733
First seen Feb 25, 2026 · Last updated May 25, 2026 · Updated 6 times
Summary
This study tested a drug called bimekizumab in 133 Chinese adults with moderate to severe plaque psoriasis. Participants received either the drug or a placebo for 16 weeks. The main goal was to see if bimekizumab could significantly clear skin compared to placebo. This is a disease-control treatment, not a cure, as ongoing management is typically needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PLAQUE PSORIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ps0041 20022
Hangzhou, China
-
Ps0041 20023
Beijing, China
-
Ps0041 20117
Guangzhou, China
-
Ps0041 20120
Wuhan, China
-
Ps0041 20136
Tianjin, China
-
Ps0041 20184
Shenzhen, China
-
Ps0041 20193
Hangzhou, China
-
Ps0041 20247
Beijing, China
-
Ps0041 20296
Hangzhou, China
-
Ps0041 20306
Beijing, China
-
Ps0041 20308
Shanghai, China
-
Ps0041 20309
Xi'an, China
-
Ps0041 20310
Ningbo, China
-
Ps0041 20311
Guangzhou, China
-
Ps0041 20312
Jinan, China
-
Ps0041 20313
Guangzhou, China
-
Ps0041 20314
Wuxi, China
-
Ps0041 20318
Jinan, China
Conditions
Explore the condition pages connected to this study.